EE370 Cost Effectiveness Evaluation of Dapagliflozin in the Treatment of Chronic Kidney Disease in Mexico
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.616
https://www.valueinhealthjournal.com/article/S1098-3015(22)02820-0/fulltext
Title :
EE370 Cost Effectiveness Evaluation of Dapagliflozin in the Treatment of Chronic Kidney Disease in Mexico
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02820-0&doi=10.1016/j.jval.2022.09.616
First page :
Section Title :
Open access? :
No
Section Order :
10151